Showing results (361-370 of 399) with videos related to

Sort By:
Pageof 40
Frontiers in Immunology|December 5, 2017
l-Citrulline Metabolism in Mice Augments CD4<sup>+</sup> T Cell Proliferation and Cytokine Production <i>In Vitro</i>, and Accumulation in the Mycobacteria-Infected LungShannon M Lange, Melanie C McKell, Stephanie M Schmidt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)A Josting, C Rudolph, M Mapara, et al.
Nature Communications|November 14, 2025
Fibroblast growth factor signaling induces a chondrocyte-like state of peripheral nerve fibroblast during agingDragana Stefanovska, Eliza Sassu, Mehmet Tekman, et al.
Leukemia Research|January 1, 1982
Multicentre study on intensified remission induction therapy for acute myeloid leukemiaT Büchner, D Urbanitz, B Emmerich, et al.
The European Respiratory Journal|November 7, 2015
NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPDZsofia Lazar, Nina Müllner, Monica Lucattelli, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
Leukemia|September 13, 2003
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alphaU Berger, G Engelich, O Maywald, et al.
Annals of Hematology|July 20, 2000
ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomasM Hänel, N Kröger, M M Hoffknecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study GroupE Laack, N Dickgreber, T Müller, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2007
A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)Eckart Laack, Ina Thöm, Andreas Krüll, et al.
Pageof 40